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Last year a paper appeared in Cell that caused a great
degree of excitement in the scientiﬁc community. Taka-
hashi and Yamanaka (2006) described a system where
murine ﬁbroblasts, virally transduced with as few as
four stem cell factors (Oct3/4, Sox2, c-Myc, and Klf4),
reverted to an embryonic stem (ES) cell-like phenotype
when placed in selective culture conditions. Last month,
the same team extended this work, this time showing
transduced cells selected for reactivation of the homeo-
protein Nanog were even more similar to ES cells than
before, and capable of germline transmission (Okita
et al., 2007). Two other teams, those of Konrad Hoc-
hedlinger (Maherali et al., 2007) and Rudolf Jaenisch
(Wernig et al., 2007), concurrently demonstrated the
remarkable capacity of this new approach. Figure 1
illustrates the general experimental design used by all of
these reports.
Taken together, the data presented by these four pa-
pers show the transduced cells display characteristics
strikingly similar to ES cells in every assay to which they
were subjected. Table 1 highlights the analyses used in
each study. These cells reactivate pluripotency genes and
present gene expression proﬁles strikingly similar to bona
ﬁde ES cells. Furthermore, epigenetic analysis showed
the cells to have DNA methylation and histone modi-
ﬁcation patterns virtually indistinguishable from ES cells,
both globally and at loci associated with pluripotency.
Importantly, this also includes analysis at imprinted loci,
suggesting that the cells being reprogrammed are not
contaminating germ cells. Perhaps most signiﬁcantly all
three groups have subjected their cells to a battery of
functional assays for developmental potential. These in-
clude formation of the three germ layers in embryoid
bodies and teratomas, high chimeric contribution, and,
crucially, germ line transmission, including live, fertile
mice obtained by Yamanaka’s group. Two additional
experiments bolster this evidence of pluripotency: ﬁrst,
Hochedlinger’s group has shown cells have the capacity
to reprogram somatic cells by cell fusion, and second,
Jaenisch’s group presented evidence of mid-gestation
tetraploid complementation embryos derived from these
cells, and hence were named ‘induced Pluripotent Stem
(iPS) cells’.
While the result presented by Hochedlinger’s group
that iPS cells generated from adult cells can contribute
to a chimera’s germline is compelling in contrast with
the germline-competent reprogramming of embryonic
ﬁbroblasts shown by other groups, these adult tail-tip
ﬁbroblasts are nonetheless a very heterogeneous popu-
lation and it remains to be demonstrated whether ter-
minally diﬀerentiated cells can be reprogrammed in this
fashion, as has been demonstrated with other repro-
gramming technologies (Tada et al., 2001; Hochedlinger
and Jaenisch, 2002; Eggan et al., 2004; Inoue et al.,
2005). Furthermore, the continued presence of trans-
genes encoding oncogenic factors and delivered by
oncogenic retroviruses (Hochedlinger et al., 2005;
Yamanaka, 2007) raises concerns about the long-term
capacity of these cells to support normal development.
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chimeras reported in these studies, approximately one-
ﬁfth developed tumors, likely due to reactivation of
the c-Myc retrovirus (Okita et al., 2007). Perhaps this
problem could be addressed by removal of the trans-
genes after reprogramming or by an inducible system
for all four factors, as was carried out by Hochedlinger
with Oct3/4 alone.
This second concern is particularly crucial to sur-
mount if this system is to be of use clinically. While the
recapitulation of this technology in human cells could
address two important challenges currently faced by the
stem cell ﬁeld, the need to avoid immune rejection by
creating pluripotent cells genetically identical to a pa-
tient and objections of some to the use of surplus
preimplantation human embryos, this demonstrated
connection to oncogenesis presents for now a signiﬁcant
barrier to such application. Likewise, identifying the
appropriate factors and selection regime to produce
human iPS cells may require an extensive amount of
new work and insight. New methodologies to either
deliver or activate these genes will also need to be de-
veloped, as suggested by both Yamanaka and Jaenisch,
in order to avoid the use of potentially cancer-causing
retroviruses.
In addition to describing a new system for generating
pluripotent cells, which may be clinically relevant, this
work provides major insights into how nuclear repro-
Table1 Summary of published iPS papers
Paper (Group) Takahashi and
Yamanaka
(2006)
(Yamanaka)
Okita et al.
(2007)
(Yamanaka)
Wernig et al.
(2007)
(Jaenisch)
Maherali et al.
(2007)
(Hochedlinger)
Selection Fbx15 Nanog Oct3/4, Nanog Oct3/4, Nanog
Cell type(s) MEF, TTF MEF MEF, TTF MEF, TTF
Frequency (iPS/ﬁbroblasts) 0.01%–0.5% 0.001%–0.03% Oct3/4: 0.08%
Nanog: 0.005%
ND
Reprograming assays
Functional
Chimera contribution 1/
1 111
Teratoma formation 111 1
Germline contribution From MEF From MEF From TTF
Cell fusion 1
Genetic/epigenetic
Gene expression analysis 111 1
Gene-speciﬁc DNA methylation 111 1
Genome-wide DNA methylation 11
Imprinting 111
Xi reactivation 1
Experimental details of the four iPS papers are shown, in addition to the functional and other assays used to illustrate nuclear reprogram-
ming.
1Chimeric contribution limited to midgestation embryos in this study.
MEF, murine embryonic ﬁbroblasts; TTF, tail-tip ﬁbroblasts; ND, not disclosed; iPS, induced pluripotent stem cell.
Selection
P
P
Fig.1 Reprogramming the diﬀerentiated state by viral transduc-
tion. The approach initially outlined by Takahashi and Yamana-
naka (2006) involves the transduction of ﬁbroblast populations
(both embryonic and adult) with four pluripotent stem cell factors
Klf4, Oct3/4, Sox2, and c-Myc. Transduced cells are then placed
under neomycin selection for reactivation of a stem cell-speciﬁc
promoter (P
SC), such as Fbx15, Oct3/4,o rNanog. Resultant
colonies were subsequently analyzed functionally, genetically, and
epigenetically to assess to what degree they behave like bona ﬁde ES
cells.
578gramming itself proceeds and as such may be able to
inform us about fundamental mechanisms of cellular
identity. How amenable is cell identity to being altered
in this fashion? Can this approach be generalized to
reprogram a variety of diﬀerent cell types? And, further,
can it be used to identify various factors or regiments to
regress diﬀerentiated states in a stepwise fashion, hence
generating progenitors and precursors as well as fully
pluripotent cells?
Certainly the advances reported in these studies cre-
ate a myriad of opportunities for new directions in
controlling and manipulating diﬀerentiation. It will be
interesting to see how this ﬁeld progresses.
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